FDA Draft Guidance Provides Definitions, Recommendations For Custom Devices
This article was originally published in The Gray Sheet
FDA’s draft guidance defines terms used in its custom device exemption, which limits the production of such devices to “five units per year of a particular device type,” and provides recommendations for information to be included in annual reports.
You may also be interested in...
Congress has settled on final language for the FDA Safety and Innovation Act. After Senate approval, the bill will go to the White House for President Obama’s signature.
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.